Sharma, V., Bagrodia, V. and Kulshreshtra, A. (2024) “Enhancing hemophilia A management: emicizumab as a cost-effective adjunct to standard therapy for inhibitor patients”, International Journal of Basic & Clinical Pharmacology, 13(3), pp. 395–397. doi: 10.18203/2319-2003.ijbcp20241000.